Austin Mary T, Nguyen Hoang, Eberth Jan M, Chang Yuchia, Heczey Andras, Hughes Dennis P, Lally Kevin P, Elting Linda S
Department of Pediatrics, Children's Cancer Hospital at the University of Texas M.D. Anderson Cancer Center, Houston, Texas; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; Department of Pediatric Surgery, The University of Texas Medical School at Houston, Houston, Texas.
Department of Health Services Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
J Pediatr Surg. 2015 Jan;50(1):161-6. doi: 10.1016/j.jpedsurg.2014.10.037. Epub 2014 Oct 26.
The purpose of this study was to identify health disparities in children with non-CNS solid tumor malignancies and examine their impact on disease presentation and outcome.
We examined the records of all children (age≤18years) diagnosed with a non-CNS solid tumor malignancy and enrolled in the Texas Cancer Registry between 1995 and 2009 (n=4603). The primary outcome measures were disease stage and overall survival (OS). Covariates included gender, age, race/ethnicity, year of diagnosis, socioeconomic status (SES), and driving distance to the nearest pediatric cancer treatment facility. Statistical analyses included life table methods, logistic, and Cox regression. Statistical significance was defined as p<0.05.
Children with advanced-stage disease were more likely to be male, <10years old, and Hispanic or non-Hispanic Blacks (all p<0.05). Distance to treatment and SES did not impact stage of disease at presentation. However, Hispanic and non-Hispanic Blacks and patients in the lowest SES quartile had the worst 1- and 5-year survival (all p<0.05). The adjusted OS differed by age, race, and stage, but not SES or distance to the nearest treatment facility.
Race/ethnicity plays an important role in survival for children with non-CNS solid tumor malignancies. Future work should better define these differences to establish mechanisms to decrease their impact.
本研究旨在确定非中枢神经系统实体瘤恶性肿瘤患儿的健康差异,并探讨其对疾病表现和预后的影响。
我们查阅了1995年至2009年期间在德克萨斯癌症登记处登记的所有诊断为非中枢神经系统实体瘤恶性肿瘤的儿童(年龄≤18岁)的记录(n = 4603)。主要结局指标为疾病分期和总生存期(OS)。协变量包括性别、年龄、种族/民族、诊断年份、社会经济地位(SES)以及到最近的儿科癌症治疗机构的驾车距离。统计分析包括生命表法、逻辑回归和Cox回归。统计学显著性定义为p<0.05。
晚期疾病患儿更可能为男性、年龄<10岁以及西班牙裔或非西班牙裔黑人(均p<0.05)。到治疗机构的距离和SES对就诊时的疾病分期没有影响。然而,西班牙裔和非西班牙裔黑人以及SES最低四分位数的患者1年和5年生存率最差(均p<0.05)。调整后的OS因年龄、种族和分期而异,但与SES或到最近治疗机构的距离无关。
种族/民族在非中枢神经系统实体瘤恶性肿瘤患儿的生存中起着重要作用。未来的工作应更好地界定这些差异,以建立减少其影响的机制。